Insider · CIK 0001830177
Tomas Kiselak
directorowner
Files at ORKA (Oruka Therapeutics, Inc.), CBIO (CRESCENT BIOPHARMA, INC.), VRDN (Viridian Therapeutics, Inc.\DE), SYRE (Spyre Therapeutics, Inc.), KRSA (Cyclerion Therapeutics, Inc.), JBIO (Jade Biosciences, Inc.), ZBIO (Zenas BioPharma, Inc.), APGE (Apogee Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | VRDN Viridian Therapeutics, Inc.\DE | AGrant or award Stock Option (Right to Buy)derivativeindirect: See Footnote | +21,000 | $0.00 | $0 | 21,000 | Jul 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.